Market Cap 11.51M
Revenue (ttm) 0.00
Net Income (ttm) -11.62M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -0.16
Volume 819,600
Avg Vol 1,676,626
Day's Range N/A - N/A
Shares Out 9.84M
Stochastic %K 34%
Beta 0.22
Analysts Strong Sell
Price Target $7.50

Company Profile

Brainstorm Cell Therapeutics Inc. a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company's NurOwn proprietary cell therapy platform that leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and enhance...

Industry: Biotechnology
Sector: Healthcare
Phone: 201 488 0460
Address:
1325 Avenue of Americas, 28th Floor, New York, United States
Letstreatals
Letstreatals Aug. 22 at 12:31 AM
0 · Reply
uieriwer
uieriwer Aug. 20 at 10:57 PM
$BCLI ahhh checking in on my BCLI crew and as always we're still waiting for Chaim's next promise! LOL. The goat!
0 · Reply
thres
thres Aug. 20 at 3:19 PM
$BCLI ALS Patient – Strong Nurown Activist had this to say after watching this Video Clip on TIK-TOK "Does anybody happen to know of any patients who claimed they stabilized (or even improved slightly) slightly after multiple doses of Nuronw. I can name a dozen in 10 seconds. So: Can you believe the audacity of these people now? IMO this video is the modern day rally cry for lack of credibility in ALS. Remember that the alsassociation issued a formal statement on Nurown saying essentially that all the claims of success Nurown patients made (and not just one) that Dr.Bedlack repeats here for Qualsody were not supported by what is saw. What a farce. See how ALS really works. They don't attempt to hide their blatant ALSBIAS anymore. "We automatically believe BioGen patient X, but not BCLI patients A,B,C,D Wait, what? " 2,000 unread testimonies for Ad-Com, Nurown rejected after 6 trials, 100M$ of research and strong patient following and no petition support or funding from ALS charities?
1 · Reply
Pipemajors82
Pipemajors82 Aug. 20 at 2:05 PM
$BCLI, I guess we sit here and wait for FDA to tell us what we can/can't do next.
0 · Reply
Knuckles30
Knuckles30 Aug. 19 at 6:28 PM
$BCLI Judah Tell us your Rabbi story?? not to many shares trading
2 · Reply
DoctorJT
DoctorJT Aug. 19 at 5:22 AM
$BCLI should the Citizen Petition fail, it appears a new precedence has been set and means the FDA is not untouchable any longer. I’d think our new EAP data would be pretty compelling in an impartial court of law. Although, I suspect things playing out in court would not be nearly as expeditious as investors want it to be, nor pALS need it to be. https://www.prnewswire.com/news-releases/in-a-major-win-for-vanda-a-federal-appeals-court-overturns-fdas-order-denying-approval-of-hetlioz-for-the-treatment-of-jet-lag-disorder-302531842.html
2 · Reply
thres
thres Aug. 19 at 4:59 AM
$BCLI Hang in there everybody. It is not the CEO's or the BOD's fault if the FDA Ad-Com rejected Nurown even after 6 ALS trials and 100M$ always gaining momentum with strong patient and public support and 2,000 unread letters to Ad-Com, deniers/opponents have more traction. I don't want to offend anybody, figure it out. ALS patients know Nurown works for many ALS Cases and gives them a better option than "works for some of the 3% of Cases (Qalsody)", hang in there, fight the good fight with ALS patients, warriors and Nurown supporters. Support team Nurown not deniers/opponents. See Matt Bellina's Right to Try Experience (FDA Ad-Com did not read his testimony, Matt is certainly not blaming the board) "But once he received NurOwn, that lethal trajectory changed. Matt's VA medical records document that instead of losing nearly 3 points in 6 months, he regained 6 points of function. This is a 9-point delta. This doesn't happen in ALS. But it did on NurOwn." nurownworks.com
1 · Reply
judah10
judah10 Aug. 19 at 4:57 AM
$BCLI for whatever my comment is worth ,i knew this Rabbi personally and the story is 100% true This why as nurown gets cheaper and cheaper, i buy more and more
0 · Reply
judah10
judah10 Aug. 19 at 4:52 AM
1 · Reply
thres
thres Aug. 18 at 5:06 AM
$BCLI See the video clip in the article, first time I head about Nurown Real World Experience in 2017: the clip goes back 03Jul12. "Rabbi Shmuelevitz, who suffered from both Amyotrophic Lateral Sclerosis and Myasthenia Gravis, had participated in an experimental stem cell treatment at Hadassah Medical Center in 2012 with promising results." "The formerly wheelchair bound rosh yeshiva who had been incapable of speaking clearly responded favorably to the clinical trial, showing substantial improvements for six months before the effects of the protocol began to fade. A second course of the NurOwn treatment, developed by Israel’s BrainStorm Cell Therapeutics, yielded even better results. Rabbi Shmuelevitz was touted as the poster child for the experimental treatment because he showed the greatest improvement of all 24 patients in the clinical trial which slowed the progress of ALS but could not halt the dreaded disease, which is currently incurable." https://vinnews.com/2016/01/18/jerusalem-torah-world-mourns-rabbi-rafael-shmuelevitz/
2 · Reply
Latest News on BCLI
No data available.
Letstreatals
Letstreatals Aug. 22 at 12:31 AM
0 · Reply
uieriwer
uieriwer Aug. 20 at 10:57 PM
$BCLI ahhh checking in on my BCLI crew and as always we're still waiting for Chaim's next promise! LOL. The goat!
0 · Reply
thres
thres Aug. 20 at 3:19 PM
$BCLI ALS Patient – Strong Nurown Activist had this to say after watching this Video Clip on TIK-TOK "Does anybody happen to know of any patients who claimed they stabilized (or even improved slightly) slightly after multiple doses of Nuronw. I can name a dozen in 10 seconds. So: Can you believe the audacity of these people now? IMO this video is the modern day rally cry for lack of credibility in ALS. Remember that the alsassociation issued a formal statement on Nurown saying essentially that all the claims of success Nurown patients made (and not just one) that Dr.Bedlack repeats here for Qualsody were not supported by what is saw. What a farce. See how ALS really works. They don't attempt to hide their blatant ALSBIAS anymore. "We automatically believe BioGen patient X, but not BCLI patients A,B,C,D Wait, what? " 2,000 unread testimonies for Ad-Com, Nurown rejected after 6 trials, 100M$ of research and strong patient following and no petition support or funding from ALS charities?
1 · Reply
Pipemajors82
Pipemajors82 Aug. 20 at 2:05 PM
$BCLI, I guess we sit here and wait for FDA to tell us what we can/can't do next.
0 · Reply
Knuckles30
Knuckles30 Aug. 19 at 6:28 PM
$BCLI Judah Tell us your Rabbi story?? not to many shares trading
2 · Reply
DoctorJT
DoctorJT Aug. 19 at 5:22 AM
$BCLI should the Citizen Petition fail, it appears a new precedence has been set and means the FDA is not untouchable any longer. I’d think our new EAP data would be pretty compelling in an impartial court of law. Although, I suspect things playing out in court would not be nearly as expeditious as investors want it to be, nor pALS need it to be. https://www.prnewswire.com/news-releases/in-a-major-win-for-vanda-a-federal-appeals-court-overturns-fdas-order-denying-approval-of-hetlioz-for-the-treatment-of-jet-lag-disorder-302531842.html
2 · Reply
thres
thres Aug. 19 at 4:59 AM
$BCLI Hang in there everybody. It is not the CEO's or the BOD's fault if the FDA Ad-Com rejected Nurown even after 6 ALS trials and 100M$ always gaining momentum with strong patient and public support and 2,000 unread letters to Ad-Com, deniers/opponents have more traction. I don't want to offend anybody, figure it out. ALS patients know Nurown works for many ALS Cases and gives them a better option than "works for some of the 3% of Cases (Qalsody)", hang in there, fight the good fight with ALS patients, warriors and Nurown supporters. Support team Nurown not deniers/opponents. See Matt Bellina's Right to Try Experience (FDA Ad-Com did not read his testimony, Matt is certainly not blaming the board) "But once he received NurOwn, that lethal trajectory changed. Matt's VA medical records document that instead of losing nearly 3 points in 6 months, he regained 6 points of function. This is a 9-point delta. This doesn't happen in ALS. But it did on NurOwn." nurownworks.com
1 · Reply
judah10
judah10 Aug. 19 at 4:57 AM
$BCLI for whatever my comment is worth ,i knew this Rabbi personally and the story is 100% true This why as nurown gets cheaper and cheaper, i buy more and more
0 · Reply
judah10
judah10 Aug. 19 at 4:52 AM
1 · Reply
thres
thres Aug. 18 at 5:06 AM
$BCLI See the video clip in the article, first time I head about Nurown Real World Experience in 2017: the clip goes back 03Jul12. "Rabbi Shmuelevitz, who suffered from both Amyotrophic Lateral Sclerosis and Myasthenia Gravis, had participated in an experimental stem cell treatment at Hadassah Medical Center in 2012 with promising results." "The formerly wheelchair bound rosh yeshiva who had been incapable of speaking clearly responded favorably to the clinical trial, showing substantial improvements for six months before the effects of the protocol began to fade. A second course of the NurOwn treatment, developed by Israel’s BrainStorm Cell Therapeutics, yielded even better results. Rabbi Shmuelevitz was touted as the poster child for the experimental treatment because he showed the greatest improvement of all 24 patients in the clinical trial which slowed the progress of ALS but could not halt the dreaded disease, which is currently incurable." https://vinnews.com/2016/01/18/jerusalem-torah-world-mourns-rabbi-rafael-shmuelevitz/
2 · Reply
afc2881
afc2881 Aug. 17 at 6:43 PM
$BCLI From Petition:
2 · Reply
thres
thres Aug. 17 at 5:15 AM
$BCLI Back during the ALS trials there was a lot of support for all the petitions, with record numbers and a lot of media coverage with ALS patients feeling better than they had in years/months. Nothing comparable has happened in ALS since the last ALS patients received Nurown. Let's all think about that and support the Nurown Team in all their endeavors. ALS is the worst disease and I have been hearing since day 1 Nurown works for many ALS patients. Cannot find that news coverage but this a great is dated 2019, we will see more like that once the trial starts or Nurown is approved, he can ride a motorbike and build a concrete block wall too, we've seen the pictures too. Go Nurown!!!
0 · Reply
Justinups
Justinups Aug. 16 at 8:29 PM
$BCLI However, there are also many other "real stem cell developers", notably those working with iPSCs. That tech could perhaps be combined with this tech too though, and that could get really interesting.
0 · Reply
Justinups
Justinups Aug. 16 at 8:29 PM
$BCLI Think there's a pretty good chance here... RFK, Prasad, recent approval without gold standard RCT, citizen's petition, and not many other options for about a 100% death rate condition that already has a lot of buy in and demand from ALS folks. RFK said in October he's going to end the "aggressive suppression" of "stem cell therapy" (amongst other things). He has also been pulling meetings with lead stem cell companys/physicians in the past few months to figure out how to change things without creating a wild west environment. Lastly, there are a lot of stem cell companies out there, most seem to use umbilical derived or bone marrow derived, and just reinject that. There are several what I call "real stem cell developers" who take that, put it in a lab (like Brainstorm) and alter them to make them more powerful/targeted. If theirs does that for neuro conditions, that has the potential to spill over to Alzeihmers, Parkinson's, TBI, Spinal cord, many other unanswered conditions.
0 · Reply
afc2881
afc2881 Aug. 16 at 7:44 PM
$BCLI Pipe Oct 3rd would be deadline, but i hope Fda acts sooner. Pals are in desperate need of treatment.
0 · Reply
Pipemajors82
Pipemajors82 Aug. 16 at 1:02 PM
$BCLI does anybody have an idea of where in the process the FDA is on the citizens' petition? 309 pages is a lot of data to review. I've never heard of a Citizens petition.
3 · Reply
Letstreatals
Letstreatals Aug. 15 at 6:12 PM
1 · Reply
ZacksSCR
ZacksSCR Aug. 15 at 5:27 PM
$BCLI: Focused on Initiation of Phase 3b ENDURANCE Trial of NurOwn® in ALS… https://buff.ly/KLychw1
1 · Reply
Letstreatals
Letstreatals Aug. 15 at 4:56 PM
0 · Reply
tceggjd
tceggjd Aug. 15 at 12:26 PM
Dr. Prasad’s comments in connection with the Papzimeos approval yesterday have interesting implications for companies like $BCLI and $SGMO (among many others) - “Randomized trials are not always needed to approve medical products and this approval is proof of that philosophy,” said Vinay Prasad, M.D., M.P.H., Director of the FDA’s Center for Biologics Evaluation and Research (CBER). “The FDA will always demand the correct clinical study for the specific medical product and disease. Our requirements for products given to tens of millions of healthy people will be different than products given to at most hundreds or thousands of patients with unique diseases.”
1 · Reply
d_risk
d_risk Aug. 14 at 4:04 PM
$BCLI - BRAINSTORM CELL THERAPEUTICS INC. - 10Q - Updated Risk Factors BCLI warns of negative impacts from its move to OTCQB, heightened macro and tariff risks affecting global markets, and ongoing internal control weaknesses that could hinder financing if unresolved. #Biotechnology #InternalControlWeaknesses #TariffImpact #MacroeconomicRisks #OTCQBListing 🟢 Added 🟠 Removed https://d-risk.ai/BCLI/10-Q/2025-08-14
1 · Reply
Strout100
Strout100 Aug. 14 at 3:39 PM
$BCLI I vote for pals and no more excuses to run the BODs and have someone from no more excuses to be the new CEO, I believe we would get tremendous support and financing and the smartest biotech brains would flock to be part of something BIG! Just a thought
1 · Reply